Quick Win by the Algorithm: PPHM’s Development of New Cancer Diagnostic Technology

Quick Win by the Algorithm

On February 14, 2017, the I Know First algorithm had predicted a bullish forecast for Peregrine Pharmaceuticals, Inc. (PPHM). It had a signal of 45.30 and a predictability of 0.08. In accordance with the algorithm, the company reported gain of 48.65% in just 3 days.

Quick Win

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company.  Founded in 1981, the company focus on the research, development and commercialization of novel therapeutics for cancer and a wide range of viral diseases.   

Quick Win

Peregrine Pharmaceuticals Inc. (PPHM) recently published positive proof-of-concept data for a new exosome-based cancer detection platform.  Moreover, such a cancer detection platform could yield the company high returns in the future.

The study data allows for a clear distinction between healthy individuals and patients with ovarian tumors. The inferences are based on the levels of exosomes containing phosphatidylserine (PS), which is a component of the cell membrane that performs a key role in cell cycle signaling.  If so, the healthcare industry could show immense interest.

Peregrine continues to develop the platform, aimed at building a suitable test for further clinical testing. It is seeking a strategic partner for further development and commercialization of the concept, which it believes offers a unique cancer detection technique. To the investors, this is a very promising path, and perhaps the reason why the stock surged in the last few days.

This bullish forecast on PPHM was sent to current I Know First subscribers on February 14, 2017. 

Before making any trading decisions, consult the latest forecast as the algorithm constantly updates predictions daily. While the algorithm can be used for intra-day trading the predictability tends to become stronger with forecasts over longer time-horizons such as the 1-month, 3-month and 1-year forecasts.

Missed the latest trend? Looking for the next best market opportunity? Find out today’s stock forecast based on our advanced self-learning algorithm